MHR
GILD icon

Matthew Hamilton Rosenberg’s Gilead Sciences GILD Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$436K Buy
3,450
+945
+38% +$125K 0.08% 119
2026
Q1 		$349K Sell
2,505
-42
-2% -$5.88K 0.07% 137
2025
Q4 		$313K Buy
2,547
+25
+1% +$3.04K 0.06% 143
2025
Q3 		$280K Hold
2,522
– – 0.06% 159
2025
Q2 		$280K Buy
2,522
+304
+14% +$32.4K 0.07% 154
2025
Q1 		$249K Hold
2,218
– – 0.06% 155
2024
Q4 		$205K Buy
2,218
+50
+2% +$4.5K 0.05% 176
2024
Q3 		$182K Hold
2,168
– – 0.05% 206
2024
Q2 		$149K Hold
2,168
– – 0.04% 226
2024
Q1 		$158K Buy
2,168
+57
+3% +$4.38K 0.05% 227
2023
Q4 		$171K Sell
2,111
-39
-2% -$3.04K 0.05% 209
2023
Q3 		$161K Buy
2,150
+56
+3% +$4.31K 0.05% 205
2023
Q2 		$161K Buy
2,094
+42
+2% +$3.35K 0.05% 210
2023
Q1 		$170K Buy
2,052
+1
+0% +$83 0.05% 212
2022
Q4 		$176K Buy
2,051
+66
+3% +$5.23K 0.06% 200
2022
Q3 		$122K Buy
1,985
+53
+3% +$3.34K 0.05% 247
2022
Q2 		$120K Buy
1,932
+71
+4% +$4.4K 0.05% 263
2022
Q1 		$111K Buy
1,861
+1,225
+193% +$78.3K 0.04% 286
2021
Q4 		$46K Sell
636
-236
-27% -$16.3K 0.02% 426
2021
Q3 		$61K Buy
872
+348
+66% +$24.4K 0.02% 363
2021
Q2 		$36K Sell
524
-61
-10% -$4.07K 0.02% 407
2021
Q1 		$28K Buy
585
+156
+36% +$10.1K 0.02% 404
2020
Q4 		$25K Sell
429
-1,349
-76% -$81.4K 0.02% 403
2020
Q3 		$112K Sell
1,778
-947
-35% -$65.7K 0.08% 181
2020
Q2 		$210K Buy
2,725
+584
+27% +$44.8K 0.17% 77
2020
Q1 		$161K Buy
+2,141
New +$148K 0.16% 69

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Matthew Hamilton Rosenberg's GILD Position: Q2 2026 in Review

Matthew Hamilton Rosenberg increased its Gilead Sciences (GILD) stake by 38% in Q2 2026, buying an estimated $125K and bringing the position to 3,450 shares worth $436K. The position accounts for 0.08% of the portfolio, ranked #119.

Matthew Hamilton Rosenberg first reported a position in GILD in Q1 2020 and has held it in 26 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Matthew Hamilton Rosenberg held 3,450 shares of Gilead Sciences worth $436K as of Q2 2026.
  • Matthew Hamilton Rosenberg bought 945 Gilead Sciences shares in Q2 2026, an estimated $125K.
  • Gilead Sciences made up 0.08% of Matthew Hamilton Rosenberg's portfolio in Q2 2026, its #119 holding.
  • Matthew Hamilton Rosenberg first reported a position in Gilead Sciences in Q1 2020 and has held it in 26 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.